Incretin ‐based glucose‐lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio‐vascular outcome trials

Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Tags: LETTER TO THE EDITOR Source Type: research